These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
77 related items for PubMed ID: 10543323
1. Interstitial alpha-smooth muscle actin: a prognostic marker in membranous nephropathy. Badid C, Desmoulière A, McGregor B, Costa AM, Fouque D, Hadj Aïssa A, Laville M. Clin Nephrol; 1999 Oct; 52(4):210-7. PubMed ID: 10543323 [Abstract] [Full Text] [Related]
2. Quantitative analysis of interstitial mast cells in lupus and non-lupus membranous glomerulopathy. Danilewicz M, Wagrowska-Danilewicz M. Pol J Pathol; 2001 Oct; 52(4):211-7. PubMed ID: 11915183 [Abstract] [Full Text] [Related]
3. Myofibroblasts and the progression of experimental glomerulonephritis. Zhang G, Moorhead PJ, el Nahas AM. Exp Nephrol; 1995 Oct; 3(5):308-18. PubMed ID: 7583053 [Abstract] [Full Text] [Related]
4. The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. Ranieri E, Gesualdo L, Grandaliano G, Maiorano E, Schena FP. J Nephrol; 2001 Oct; 14(4):253-62. PubMed ID: 11506247 [Abstract] [Full Text] [Related]
5. Nestin is a novel marker for renal tubulointerstitial injury in immunoglobulin A nephropathy. Tomioka M, Hiromura K, Sakairi T, Takeuchi S, Maeshima A, Kaneko Y, Kuroiwa T, Takeuchi T, Nojima Y. Nephrology (Carlton); 2010 Aug; 15(5):568-74. PubMed ID: 20649878 [Abstract] [Full Text] [Related]
6. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. Heeringa SF, Branten AJ, Deegens JK, Steenbergen E, Wetzels JF. Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739 [Abstract] [Full Text] [Related]
7. Addition of oleic acid to delipidated bovine serum albumin aggravates renal damage in experimental protein-overload nephrosis. van Timmeren MM, Bakker SJ, Stegeman CA, Gans RO, van Goor H. Nephrol Dial Transplant; 2005 Nov; 20(11):2349-57. PubMed ID: 16144858 [Abstract] [Full Text] [Related]
8. [The role of smooth muscle alpha-actin in development of renal fibrosis in patients with chronic glomerulonephritis]. Chebotareva NV, Bobkova IN, Varshavskiĭ VA, Golitsyna EP, Kozlovskaia LV. Ter Arkh; 2006 Nov; 78(5):17-21. PubMed ID: 16889044 [Abstract] [Full Text] [Related]
9. A morphometric insight into glomerular and interstitial lesions in acutely rejected renal allografts. Danilewicz M, Wagrowska-Danilewicz M. Pol J Pathol; 2003 Nov; 54(3):171-7. PubMed ID: 14703283 [Abstract] [Full Text] [Related]
10. Low glomerular density is a risk factor for progression in idiopathic membranous nephropathy. Tsuboi N, Kawamura T, Miyazaki Y, Utsunomiya Y, Hosoya T. Nephrol Dial Transplant; 2011 Nov; 26(11):3555-60. PubMed ID: 21771759 [Abstract] [Full Text] [Related]
11. Expression of cytoskeletal proteins differentiates between progressors and non-progressors in treated idiopathic membranous nephropathy. Tamimi NA, Stevens PE, O'Donnell PL, Strange PG, Muchaneta-Kubara EC, El Nahas AM. Exp Nephrol; 1998 Nov; 6(3):217-25. PubMed ID: 9639037 [Abstract] [Full Text] [Related]
12. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis. Dumoulin A, Hill GS, Montseny JJ, Meyrier A. Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220 [Abstract] [Full Text] [Related]
13. Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction. Badid C, Desmouliere A, Babici D, Hadj-Aissa A, McGregor B, Lefrancois N, Touraine JL, Laville M. Nephrol Dial Transplant; 2002 Nov; 17(11):1993-8. PubMed ID: 12401859 [Abstract] [Full Text] [Related]
14. Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Goumenos DS, Brown CB, Shortland J, el Nahas AM. Nephrol Dial Transplant; 1994 Nov; 9(10):1418-25. PubMed ID: 7816254 [Abstract] [Full Text] [Related]
15. Increased density of interstitial mast cells in amyloid A renal amyloidosis. Tóth T, Tóth-Jakatics R, Jimi S, Takebayashi S. Mod Pathol; 2000 Sep; 13(9):1020-8. PubMed ID: 11007043 [Abstract] [Full Text] [Related]
16. Relevance of periglomerular myofibroblasts in progression of human glomerulonephritis. Oba S, Kimura K, Suzuki N, Mise N, Tojo A, Miyashita K, Konno Y, Hirata Y, Goto A, Omata M. Am J Kidney Dis; 1998 Sep; 32(3):419-25. PubMed ID: 9740158 [Abstract] [Full Text] [Related]
17. Interstitial myofibroblasts: predictors of progression in membranous nephropathy. Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam LJ. J Clin Pathol; 1997 Feb; 50(2):123-7. PubMed ID: 9155692 [Abstract] [Full Text] [Related]
18. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. Stallone G, Infante B, Schena A, Battaglia M, Ditonno P, Loverre A, Gesualdo L, Schena FP, Grandaliano G. J Am Soc Nephrol; 2005 Dec; 16(12):3755-62. PubMed ID: 16236802 [Abstract] [Full Text] [Related]
19. Expression of transgelin in human glomerulonephritis of various etiology. Gerolymos M, Karagianni F, Papasotiriou M, Kalliakmani P, Sotsiou F, Charonis A, Goumenos DS. Nephron Clin Pract; 2011 Dec; 119(1):c74-82. PubMed ID: 21677441 [Abstract] [Full Text] [Related]
20. Prognostic significance of glomerular and tubulointerstitial morphometry in idiopathic membranous nephropathy. Horvatic I, Ljubanovic DG, Bulimbasic S, Knotek M, Prkacin I, Tisljar M, Galesic K. Pathol Res Pract; 2012 Nov 15; 208(11):662-7. PubMed ID: 22995635 [Abstract] [Full Text] [Related] Page: [Next] [New Search]